<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10022897" created="28/04/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10022897</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="A1" sem="Other">Activation</term>-dependent <term id="T1" sem="Other">transcriptional regulation</term> of the <term id="T2" lex="human_Fas_promoter" sem="DNA_domain_or_region">human Fas promoter</term> requires <term id="T3" lex="NF-kappaB_p50-p65_recruitment" sem="Other"><term id="T4" lex="NF-kappaB_p50-p65" sem="Protein_complex">NF-kappaB p50-p65</term> recruitment</term>.</sentence>
<event id="E1">
<type class="Regulation"/>
<theme idref="T2"/>
<clue>Activation-dependent transcriptional <clueType>regulation</clueType> <linkTheme>of</linkTheme> the human Fas promoter requires NF-kappaB p50-p65 recruitment.</clue>
</event>
<event id="E34">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="A1"/>
<clue>Activation-<clueType>dependent</clueType> transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment.</clue>
</event>
<event id="E2">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="E102"/>
<clue>Activation-dependent transcriptional regulation of the human Fas promoter <clueType>requires</clueType> NF-kappaB p50-p65 recruitment.</clue>
</event>
<event id="E102">
<type class="Positive_regulation"/>
<theme idref="T4"/>
<clue>Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 <clueType>recruitment</clueType>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T5" lex="Fas" sem="Protein_molecule">Fas</term> (<term id="T6" lex="CD95" sem="Protein_molecule">CD95</term>) and <term id="T7" lex="Fas_ligand" sem="Protein_molecule">Fas ligand</term> (<term id="T8" lex="CD95L" sem="Protein_molecule">CD95L</term>) are an interacting <term id="T9" lex="receptor-ligand_pair" sem="Other">receptor-ligand pair</term> required for <term id="T10" lex="immune_homeostasis" sem="Other">immune homeostasis</term>.</sentence>
<event KT="Fact" id="E3">
<type class="Binding"/>
<theme idref="T6"/>
<theme idref="T8"/>
<clue>Fas (CD95) and Fas ligand (CD95L) <clueKT>are</clueKT> an <clueType>interacting receptor-ligand pair</clueType> required for immune homeostasis.</clue>
</event>
<event KT="Other" id="E4">
<type class="Regulation"/>
<theme idref="T10"/>
<cause idref="E3"/>
<clue>Fas (CD95) and Fas ligand (CD95L) are an interacting receptor-ligand pair <clueType>required</clueType> <linkTheme>for</linkTheme> immune homeostasis.</clue>
</event>
<sentence id="S3"><term id="T11" lex="lymphocyte_activation" sem="Other"><term id="A2" sem="Cell_natural">Lymphocyte</term> activation</term> results in the upregulation of <term id="T12" lex="Fas_expression" sem="Other"><term id="T13" lex="Fas" sem="Protein_molecule">Fas</term> expression</term> and the acquisition of sensitivity to <term id="T15" lex="FasL" sem="Protein_molecule">FasL</term>-mediated <term id="A3" sem="Other">apoptosis</term>.</sentence>
<event KT="Other" id="E5">
<type class="Physiological_process"/>
<theme idref="A2"/>
<clue>Lymphocyte <clueType>activation</clueType> results in the upregulation of Fas expression and the acquisition of sensitivity to FasL-mediated apoptosis.</clue>
</event>
<event KT="Other" id="E6">
<type class="Gene_expression"/>
<theme idref="T13"/>
<clue>Lymphocyte activation results in the upregulation of Fas <clueType>expression</clueType> and the acquisition of sensitivity to FasL-mediated apoptosis.</clue>
</event>
<event KT="Fact" id="E7">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<cause idref="E5"/>
<clue>Lymphocyte activation <clueType>results in</clueType> the <clueType>upregulation</clueType> <linkTheme>of</linkTheme> Fas expression and the acquisition of sensitivity to FasL-mediated apoptosis.</clue>
</event>
<event KT="Other" id="E8">
<type class="Positive_regulation"/>
<theme idref="A3"/>
<cause idref="T15"/>
<clue>Lymphocyte activation results in the upregulation of Fas expression and the acquisition of sensitivity to FasL-<clueType>mediated</clueType> apoptosis.</clue>
</event>
<event KT="Fact" id="E9">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="E5"/>
<clue>Lymphocyte activation <clueType>results in</clueType> the upregulation of Fas expression and the <clueType>acquisition of sensitivity</clueType> <linkTheme>to</linkTheme> FasL-mediated apoptosis.</clue>
<comment>SENSITIVITY</comment></event>
<sentence id="S4">Although <term id="A4" sem="Protein_molecule">Fas</term> upregulation is central to the preservation of <term id="A5" sem="Other">immunologic tolerance</term>, little is known about the <term id="T16" lex="molecular_machinery" sem="Other">molecular machinery</term> underlying this process.</sentence>
<event KT="Other" id="E10">
<type class="Positive_regulation"/>
<theme idref="A4"/>
<clue>Although Fas <clueType>upregulation</clueType> is central to the preservation of immunologic tolerance, little is known about the molecular machinery underlying this process.</clue>
</event>
<event KT="Fact" id="E11">
<type class="Positive_regulation"/>
<theme idref="A5"/>
<cause idref="E10"/>
<clue>Although Fas upregulation is <clueType>central to</clueType> the <clueType>preservation</clueType> <linkTheme>of</linkTheme> immunologic tolerance, little is known about the molecular machinery underlying this process.</clue>
</event>
<sentence id="S5">To investigate the events involved in <term id="A6" sem="Other">activation</term>-induced <term id="T17" lex="Fas_upregulation" sem="Other"><term id="T18" lex="Fas" sem="Protein_molecule">Fas</term> upregulation</term>, we have examined <term id="T19" lex="mRNA_accumulation" sem="Other">mRNA accumulation</term>, <term id="T20" lex="fas_promoter_activity" sem="Other">fas promoter activity</term>, and <term id="T21" lex="protein_expression" sem="Other">protein expression</term> in the <term id="T22" lex="Jurkat_T-cell_line" sem="Cell_cultured">Jurkat T-cell line</term> treated with <term id="T23" lex="phorbol_myristate_acetate" sem="Organic_compound_other">phorbol myristate acetate</term> and <term id="T24" lex="ionomycin" sem="Organic_compound_other">ionomycin</term> (<term id="T25" lex="P/I" sem="Organic_compound_other">P/I</term>), pharmacological mimics of <term id="T26" lex="T-cell_receptor_activation" sem="Other"><term id="T27" lex="T-cell_receptor" sem="Protein_family_or_group">T-cell receptor</term> activation</term>.</sentence>
<event KT="Investigation" id="E12">
<type class="Positive_regulation"/>
<theme idref="T18"/>
<clue>To <clueKT>investigate</clueKT> the events involved in activation-induced Fas <clueType>upregulation</clueType>, we have examined mRNA accumulation, fas promoter activity, and protein expression in the Jurkat T-cell line treated with phorbol myristate acetate and ionomycin (P/I), pharmacological mimics of T-cell receptor activation.</clue>
</event>
<event KT="Other" id="E13">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="A6"/>
<clue>To investigate the events involved in activation-<clueType>induced</clueType> Fas upregulation, we have examined mRNA accumulation, fas promoter activity, and protein expression in the Jurkat T-cell line treated with phorbol myristate acetate and ionomycin (P/I), pharmacological mimics of T-cell receptor activation.</clue>
</event>
<event KT="Investigation" id="E14" uncertainty="doubtful">
<type class="RNA_metabolism"/>
<theme idref="T18"/>
<clue>To investigate the events involved in activation-induced Fas upregulation, we have <clueKT>examined</clueKT> <corefTheme>mRNA</corefTheme> <clueType>accumulation</clueType>, fas promoter activity, and protein expression <clueLoc>in the Jurkat T-cell line treated with phorbol myristate acetate and ionomycin (P/I)</clueLoc>, pharmacological mimics of T-cell receptor activation.</clue>
</event>
<event KT="Investigation" id="E15" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="T18"/>
<clue>To investigate the events involved in activation-induced Fas upregulation, we have <clueKT>examined</clueKT> mRNA accumulation, fas promoter activity, and <corefTheme>protein</corefTheme> <clueType>expression</clueType> <clueLoc>in the Jurkat T-cell line treated with phorbol myristate acetate and ionomycin (P/I)</clueLoc>, pharmacological mimics of T-cell receptor activation.</clue>
</event>
<event KT="Method" id="E115">
<type class="Artificial_process"/>
<theme idref="T22"/>
<theme idref="T23"/>
<theme idref="T25"/>
<clue>To investigate the events involved in activation-induced Fas upregulation, we have examined mRNA accumulation, fas promoter activity, and protein expression in the Jurkat T-cell line <clueType><clueKT>treated</clueKT></clueType> <linkTheme>with</linkTheme> phorbol myristate acetate and ionomycin (P/I), pharmacological mimics of T-cell receptor activation.</clue>
</event>
<event KT="Other" id="E215">
<type class="Positive_regulation"/>
<theme idref="T27"/>
<clue>To investigate the events involved in activation-induced Fas upregulation, we have examined mRNA accumulation, fas promoter activity, and protein expression in the Jurkat T-cell line treated with phorbol myristate acetate and ionomycin (P/I), pharmacological mimics of T-cell receptor <clueType>activation</clueType>.</clue>
</event>
<sentence id="S6">Although <term id="T28" lex="resting_Jurkat_cell" sem="Cell_cultured">resting Jurkat cells</term> express <term id="T29" lex="Fas" sem="Protein_molecule">Fas</term>, <term id="T30" lex="Fas_mRNA" sem="RNA_molecule"><term id="T31" lex="Fas" sem="Protein_molecule">Fas</term> mRNA</term> was induced approximately 10-fold in 2 h upon <term id="T32" lex="P/I" sem="Organic_compound_other">P/I</term> stimulation.</sentence>
<event KT="Fact" id="E18">
<type class="Gene_expression"/>
<theme idref="T29"/>
<clue>Although <clueLoc>resting Jurkat cells</clueLoc> <clueType>express</clueType> Fas, Fas mRNA was induced approximately 10-fold in 2 h upon P/I stimulation.</clue>
</event>
<event Manner="High" id="E19">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<cause idref="T32"/>
<clue>Although resting <clueLoc>Jurkat cells</clueLoc> express Fas, Fas mRNA was <clueType>induced</clueType> approximately <clueManner>10-fold</clueManner> <clueTime>in 2 h</clueTime> <linkCause>upon</linkCause> P/I stimulation.</clue>
</event>
<sentence id="S7">Using <term id="T33" lex="sequential_deletion_mutant" sem="DNA_family_or_group">sequential deletion mutants</term> of the <term id="T34" lex="human_fas_promoter" sem="DNA_domain_or_region">human fas promoter</term> in transient transfection assays, we identified a <term id="T35" lex="47-bp_sequence" sem="DNA_domain_or_region">47-bp sequence</term> (<term id="T36" lex="positions_-306_to_-260" sem="DNA_domain_or_region">positions -306 to -260</term> relative to the <term id="T37" lex="ATG" sem="Polynucleotide">ATG</term>) required for <term id="A8" sem="Other">activation</term>-driven <term id="T14" sem="Other"><term id="A7" sem="Protein_molecule">fas</term> upregulation</term>.</sentence>
<event KT="Other" id="E20">
<type class="Positive_regulation"/>
<theme idref="A7"/>
<cause idref="A8"/>
<clue>Using sequential deletion mutants of the human fas promoter in transient transfection assays, we identified a 47-bp sequence (positions -306 to -260 relative to the ATG) required for activation-<linkCause>driven</linkCause> fas <clueType>upregulation</clueType>.</clue>
</event>
<event KT="Analysis" id="E21">
<type class="Positive_regulation"/>
<theme idref="E20"/>
<cause idref="T35"/>
<clue>Using sequential deletion mutants of the human fas promoter <clueExperiment>in transient transfection assays</clueExperiment>, we <clueKT>identified</clueKT> a 47-bp sequence (positions -306 to -260 relative to the ATG) <clueType>required</clueType> <linkTheme>for</linkTheme> activation-driven fas upregulation.</clue>
</event>
<sentence id="S8"><term id="T39" lex="sequence_analysis" sem="Other">Sequence analysis</term> revealed the presence of a previously <term id="T40" lex="unrecognized_composite_binding_site" sem="DNA_domain_or_region">unrecognized composite binding site</term> for both the <term id="T41" lex="Sp1" sem="Protein_molecule">Sp1</term> and <term id="T42" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> <term id="T43" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term> at <term id="T44" lex="position_-295_to_-286" sem="DNA_domain_or_region">positions -295 to -286</term>.</sentence>
<sentence id="S9"><term id="T45" lex="electrophoretic_mobility_shift_assay" sem="Other">Electrophoretic mobility shift assay</term> (<term id="T46" lex="EMSA" sem="Other">EMSA</term>) and supershift analyses of this region documented constitutive binding of <term id="T47" lex="Sp1" sem="Protein_molecule">Sp1</term> in unactivated nuclear extracts and inducible binding of <term id="T48" lex="p50-p65_NF-kappaB_heterodimer" sem="Protein_complex">p50-p65 <term id="T49" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> heterodimers</term> after <term id="T50" lex="P/I" sem="Organic_compound_other">P/I</term> activation.</sentence>
<event KT="Analysis" id="E22">
<type class="Binding"/>
<theme idref="T40"/>
<theme idref="T47"/>
<clue><clueExperiment>Electrophoretic mobility shift assay (EMSA) and supershift analyses</clueExperiment> of <corefTheme>this region</corefTheme> <clueKT>documented</clueKT> constitutive <clueType>binding</clueType> <linkTheme>of</linkTheme> Sp1 <clueLoc>in unactivated nuclear extracts</clueLoc> and inducible binding of p50-p65 NF-kappaB heterodimers after P/I activation.</clue>
</event>
<event KT="Analysis" id="E23">
<type class="Binding"/>
<theme idref="T40"/>
<theme idref="T48"/>
<clue>Electrophoretic mobility shift assay (EMSA) and supershift analyses of <corefTheme>this region</corefTheme> <clueKT>documented</clueKT> constitutive binding of Sp1 in unactivated nuclear extracts and inducible <clueType>binding</clueType> <linkTheme>of</linkTheme> p50-p65 NF-kappaB heterodimers after P/I activation.</clue>
</event>
<event KT="Other" id="E24">
<type class="Physiological_process"/>
<theme idref="T22"/>
<cause idref="T50"/>
<clue>Electrophoretic mobility shift assay (EMSA) and supershift analyses of this region documented constitutive binding of Sp1 in unactivated nuclear extracts and inducible binding of p50-p65 NF-kappaB heterodimers after P/I <clueType>activation</clueType>.</clue>
<comment>No corefTheme</comment></event>
<event KT="Other" id="E25">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="E24"/>
<clue><clueExperiment>Electrophoretic mobility shift assay (EMSA) and supershift analyses</clueExperiment> of this region documented constitutive binding of Sp1 in unactivated nuclear extracts and <clueType>inducible</clueType> binding of p50-p65 NF-kappaB heterodimers <linkCause>after</linkCause> P/I activation.</clue>
</event>
<sentence id="S10"><term id="T51" lex="Sp1" sem="Protein_molecule">Sp1</term> and <term id="T52" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> <term id="T53" lex="transcription_factor_binding" sem="Other">transcription factor binding</term> was shown to be mutually exclusive by <term id="T55" lex="EMSA" sem="Other">EMSA</term> displacement studies with purified recombinant <term id="T56" lex="Sp1" sem="Protein_molecule">Sp1</term> and recombinant <term id="T57" lex="p50" sem="Protein_molecule">p50</term>.</sentence>
<event KT="Other" id="E26">
<type class="Binding"/>
<theme idref="T51"/>
<theme idref="T40"/>
<clue>Sp1 and NF-kappaB transcription factor <clueType>binding</clueType> was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.</clue>
<comment>No corefTheme</comment></event>
<event KT="Other" id="E27">
<type class="Binding"/>
<theme idref="T52"/>
<theme idref="T40"/>
<clue>Sp1 and NF-kappaB transcription factor <clueType>binding</clueType> was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.</clue>
<comment>No corefTheme</comment></event>
<event KT="Analysis" id="E28">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="E27"/>
<clue>Sp1 and NF-kappaB transcription factor binding <clueKT>was shown to be</clueKT> <clueType>mutually exclusive</clueType> <clueExperiment>by EMSA displacement studies</clueExperiment> with purified recombinant Sp1 and recombinant p50.</clue>
</event>
<event KT="Analysis" id="E33">
<type class="Negative_regulation"/>
<theme idref="E27"/>
<cause idref="E26"/>
<clue>Sp1 and NF-kappaB transcription factor binding <clueKT>was shown to be</clueKT> <clueType>mutually exclusive</clueType> <clueExperiment>by EMSA displacement studies</clueExperiment> with purified recombinant Sp1 and recombinant p50.</clue>
</event>
<sentence id="S11">The functional contribution of the <term id="T58" lex="kappaB-Sp1_composite_site" sem="DNA_domain_or_region">kappaB-<term id="T59" lex="Sp1" sem="Protein_molecule">Sp1</term> composite site</term> in <term id="T62" lex="P/I" sem="Organic_compound_other">P/I</term>-inducible <term id="T38" sem="Other"><term id="A9" sem="DNA_domain_or_region">fas promoter</term> activation</term> was verified by using kappaB-<term id="T63" lex="Sp1_concatamer" sem="Polynucleotide"><term id="T64" lex="Sp1" sem="Protein_molecule">Sp1</term> concatamers</term> (<term id="T65" lex="-295_to_-286" sem="DNA_domain_or_region">-295 to -286</term>) in a <term id="T66" lex="thymidine_kinase_promoter-driven_reporter_construct" sem="DNA_molecule">thymidine kinase promoter-driven reporter construct</term> and <term id="T67" lex="native_promoter_construct" sem="DNA_family_or_group">native promoter constructs</term> in <term id="T68" lex="Jurkat_cell" sem="Cell_cultured">Jurkat cells</term> overexpressing <term id="T69" lex="IkappaB-alpha" sem="Protein_molecule">IkappaB-alpha</term>.</sentence>
<event KT="Other" id="E29">
<type class="Positive_regulation"/>
<theme idref="A9"/>
<cause idref="T62"/>
<clue>The functional contribution of the kappaB-Sp1 composite site in P/I-<linkCause>inducible</linkCause> fas promoter <clueType>activation</clueType> was verified by using kappaB-Sp1 concatamers (-295 to -286) in a thymidine kinase promoter-driven reporter construct and native promoter constructs in Jurkat cells overexpressing IkappaB-alpha.</clue>
</event>
<event KT="Analysis" id="E30">
<type class="Correlation"/>
<theme idref="E29"/>
<theme idref="T58"/>
<clue>The functional <clueType>contribution</clueType> <linkTheme>of</linkTheme> the kappaB-Sp1 composite site <linkTheme>in</linkTheme> P/I-inducible fas promoter activation <clueKT>was verified</clueKT> by using kappaB-Sp1 concatamers (-295 to -286) in a thymidine kinase promoter-driven reporter construct and native promoter constructs <clueLoc>in Jurkat cells overexpressing IkappaB-alpha</clueLoc>.</clue>
</event>
<sentence id="S12">Site-directed mutagenesis of the critical <term id="T70" lex="guanine_nucleotide" sem="Nucleotide">guanine nucleotides</term> in the <term id="T71" lex="kappaB-Sp1_element" sem="DNA_domain_or_region">kappaB-<term id="T72" lex="Sp1" sem="Protein_molecule">Sp1</term> element</term> documented the essential role of this site in <term id="A11" sem="Other">activation</term>-dependent <term id="T54" sem="Other"><term id="A10" sem="DNA_domain_or_region">fas promoter</term> induction</term>.</sentence>
<event KT="Other" id="E31">
<type class="Positive_regulation"/>
<theme idref="A10"/>
<cause idref="A11"/>
<clue>Site-directed mutagenesis of the critical guanine nucleotides in the kappaB-Sp1 element documented the essential role of this site in activation-<linkCause>dependent</linkCause> fas promoter <clueType>induction</clueType>.</clue>
</event>
<event KT="Analysis" id="E32">
<type class="Positive_regulation"/>
<theme idref="E31"/>
<cause idref="T71"/>
<clue>Site-directed mutagenesis of the critical guanine nucleotides in the kappaB-Sp1 element <clueKT>documented</clueKT> the <clueType><clueKT>essential</clueKT> role</clueType> <linkCause>of</linkCause> <corefCause>this site</corefCause> <linkTheme>in</linkTheme> activation-dependent fas promoter induction.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
